Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Hewitt

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus MacaquesRaymond M Slay, Judith A Hewitt, Martin Crumrine
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2020
The African Green Monkey Model of Pneumonic Plague and US Food and Drug Administration Approval of Antimicrobials Under the Animal RuleJudith A Hewitt, Lynda L Lanning, Joseph L Campbell
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Evaluation of Amoxicillin and Amoxicillin-Clavulanate (Augmentin) for Antimicrobial Postexposure Prophylaxis Following Bacillus anthracis Inhalational Exposure in Cynomolgus MacaquesRaymond M Slay, Graham J Hatch, Judith A Hewitt
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2020
Effect of Delaying Treatment on Efficacy of Ciprofloxacin and Levofloxacin in the African Green Monkey Model of Pneumonic PlagueJoseph L Campbell, Michael P Fay, Lynda L Lanning, et al.
ILAR Journal|June 3, 2017
Accelerating Biomedical Discoveries through Rigor and TransparencyJudith A Hewitt, Liliana L Brown, Stephanie J Murphy, et al.
Cell Host & Microbe|November 5, 2020
ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for Vaccines and TherapeuticsJudith A Hewitt, Cathleen Lutz, William C Florence, et al.
Radiation Research|August 31, 2018
Challenges and Benefits of Repurposing Products for Use during a Radiation Public Health Emergency: Lessons Learned from Biological Threats and other Disease TreatmentsAndrea L DiCarlo, David R Cassatt, William E Dowling, et al.
Frontiers in Medicine|November 8, 2019
Retrospective Analysis of Pneumonic Tularemia in Operation Whitecoat Human Subjects: Disease Progression and Tetracycline EfficacyMark S Williams, Marianne R Baker, Tina Guina, et al.
Frontiers in Cellular and Infection Microbiology|April 20, 2018
The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal RuleTina Guina, Lynda L Lanning, Kristian S Omland, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus MacaquesRaymond M Slay, Judith A Hewitt, Martin Crumrine
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2020
The African Green Monkey Model of Pneumonic Plague and US Food and Drug Administration Approval of Antimicrobials Under the Animal RuleJudith A Hewitt, Lynda L Lanning, Joseph L Campbell
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Evaluation of Amoxicillin and Amoxicillin-Clavulanate (Augmentin) for Antimicrobial Postexposure Prophylaxis Following Bacillus anthracis Inhalational Exposure in Cynomolgus MacaquesRaymond M Slay, Graham J Hatch, Judith A Hewitt
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2020
Effect of Delaying Treatment on Efficacy of Ciprofloxacin and Levofloxacin in the African Green Monkey Model of Pneumonic PlagueJoseph L Campbell, Michael P Fay, Lynda L Lanning, et al.
ILAR Journal|June 3, 2017
Accelerating Biomedical Discoveries through Rigor and TransparencyJudith A Hewitt, Liliana L Brown, Stephanie J Murphy, et al.
Cell Host & Microbe|November 5, 2020
ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for Vaccines and TherapeuticsJudith A Hewitt, Cathleen Lutz, William C Florence, et al.
Radiation Research|August 31, 2018
Challenges and Benefits of Repurposing Products for Use during a Radiation Public Health Emergency: Lessons Learned from Biological Threats and other Disease TreatmentsAndrea L DiCarlo, David R Cassatt, William E Dowling, et al.
Frontiers in Medicine|November 8, 2019
Retrospective Analysis of Pneumonic Tularemia in Operation Whitecoat Human Subjects: Disease Progression and Tetracycline EfficacyMark S Williams, Marianne R Baker, Tina Guina, et al.
Frontiers in Cellular and Infection Microbiology|April 20, 2018
The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal RuleTina Guina, Lynda L Lanning, Kristian S Omland, et al.
Pageof 1